Call：+86 13413644741 
E-mail：market@ca-marketresearch.com Global Infectious Vaccines Market Insights, Forecast to 2028
| Lowest Price Available | Length | Published Date | Report Id |
|---|---|---|---|
| from $4,900.00 | 113 Pages | 2022-02-22 | 4396789 |
Summary:
Market Analysis and Insights: Global Infectious Vaccines Market
A vaccine is a medical product primarily designed to stimulate antibodies against an infectious disease which help to improve the immunity of the target body.
Due to the COVID-19 pandemic, the global Infectious Vaccines market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Preventive Vaccine accounting for % of the Infectious Vaccines global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Adults segment is altered to an % CAGR throughout this forecast period.
Rising consumer awareness regarding health coupled with rising disposable income is expected to propel demand for infectious vaccines over the next seven years. Furthermore, increasing government activities to control epidemic diseases such as polio, camp fever, and swine flu is projected to have impact market growth significantly over the next seven years.
Market Segments
The authors of this research report have explored the key segments: Type and Application. The report offers an in-depth breakdown of type and application segments and their sub-segments. The lucrativeness and growth potential have been looked into by the industry experts in this report. This section of the report also provides sales and revenue forecast data by type and application segments based on sales, price, and revenue for the period 2017-2028. The specialists, to broaden the understanding of the users, have done value chain and raw material analysis in this section.
Segment by Type
Preventive Vaccine
Therapeutic Vaccine
Segment by Application
Adults
Pediatrics
Consequence of Covid-19 Pandemic
The authors of this study have enlightened the readers on the rise and effect of the Covid-19 outbreak on the development. They have investigated the changes brought about in the demand/supply side, consumption, supply chain, and sales/manufacturing. The readers will get familiar with the measures that have helped the key players to bring the Infectious Vaccines market back to the pre-covid levels.
Trends & Prospects
In this segment of the report, the specialists have delved into the key growth opportunities that are likely to emerge. This will aid the key players to simplify complex issues related to business and frame future strategies to compete in this competitive environment. This section will certainly assist the players to boldly position their business.
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Competitive Outlook
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and share analysis of the prominent players are also provided in this section. They have also provided reliable sales and revenue data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
CSL Limited (Australia)
Bavarian Nordic (Denmark)
GlaxoSmithKline plc. (U.K.)
Emergent Bio Solutions Inc. (U.S.)
MedImmune LLC (U.S.)
Johnson and Johnson (U.S.)
Novartis AG (Switzerland)
Merck and Company (U.S.)
Sanofi Pasteur (France)
Pfizer Inc. (U.S.)
Frequently Asked Questions
Which is the most lucrative product segment in the Infectious Vaccines market?
Which are the prominent strategies of the Infectious Vaccines market players?
Which factors are increasing the competition in the Infectious Vaccines market?
Which are the recommendations provided by the Infectious Vaccines industry experts?
Which region will witness rewarding growth during the forecast period?
What factors will curb the Infectious Vaccines market growth?
Which product segment will register the fastest growth rate in the Infectious Vaccines market?
Which emerging trends will impact the Infectious Vaccines market growth?
Which are the high-impact rendering factors in the Infectious Vaccines market?
Which companies will maintain their lead on the Infectious Vaccines market?
Table of Contents
1 Study Coverage
1.1 Infectious Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Infectious Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Preventive Vaccine
1.2.3 Therapeutic Vaccine
1.3 Market by Application
1.3.1 Global Infectious Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Adults
1.3.3 Pediatrics
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Infectious Vaccines Sales Estimates and Forecasts 2017-2028
2.2 Global Infectious Vaccines Revenue Estimates and Forecasts 2017-2028
2.3 Global Infectious Vaccines Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Infectious Vaccines Sales by Region
2.4.1 Global Infectious Vaccines Sales by Region (2017-2022)
2.4.2 Global Sales Infectious Vaccines by Region (2023-2028)
2.5 Global Infectious Vaccines Revenue by Region
2.5.1 Global Infectious Vaccines Revenue by Region (2017-2022)
2.5.2 Global Infectious Vaccines Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Infectious Vaccines Sales by Manufacturers
3.1.1 Global Top Infectious Vaccines Manufacturers by Sales (2017-2022)
3.1.2 Global Infectious Vaccines Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Infectious Vaccines in 2021
3.2 Global Infectious Vaccines Revenue by Manufacturers
3.2.1 Global Infectious Vaccines Revenue by Manufacturers (2017-2022)
3.2.2 Global Infectious Vaccines Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Infectious Vaccines Revenue in 2021
3.3 Global Infectious Vaccines Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Infectious Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Infectious Vaccines Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Infectious Vaccines Sales by Type
4.1.1 Global Infectious Vaccines Historical Sales by Type (2017-2022)
4.1.2 Global Infectious Vaccines Forecasted Sales by Type (2023-2028)
4.1.3 Global Infectious Vaccines Sales Market Share by Type (2017-2028)
4.2 Global Infectious Vaccines Revenue by Type
4.2.1 Global Infectious Vaccines Historical Revenue by Type (2017-2022)
4.2.2 Global Infectious Vaccines Forecasted Revenue by Type (2023-2028)
4.2.3 Global Infectious Vaccines Revenue Market Share by Type (2017-2028)
4.3 Global Infectious Vaccines Price by Type
4.3.1 Global Infectious Vaccines Price by Type (2017-2022)
4.3.2 Global Infectious Vaccines Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Infectious Vaccines Sales by Application
5.1.1 Global Infectious Vaccines Historical Sales by Application (2017-2022)
5.1.2 Global Infectious Vaccines Forecasted Sales by Application (2023-2028)
5.1.3 Global Infectious Vaccines Sales Market Share by Application (2017-2028)
5.2 Global Infectious Vaccines Revenue by Application
5.2.1 Global Infectious Vaccines Historical Revenue by Application (2017-2022)
5.2.2 Global Infectious Vaccines Forecasted Revenue by Application (2023-2028)
5.2.3 Global Infectious Vaccines Revenue Market Share by Application (2017-2028)
5.3 Global Infectious Vaccines Price by Application
5.3.1 Global Infectious Vaccines Price by Application (2017-2022)
5.3.2 Global Infectious Vaccines Price Forecast by Application (2023-2028)
6 North America
6.1 North America Infectious Vaccines Market Size by Type
6.1.1 North America Infectious Vaccines Sales by Type (2017-2028)
6.1.2 North America Infectious Vaccines Revenue by Type (2017-2028)
6.2 North America Infectious Vaccines Market Size by Application
6.2.1 North America Infectious Vaccines Sales by Application (2017-2028)
6.2.2 North America Infectious Vaccines Revenue by Application (2017-2028)
6.3 North America Infectious Vaccines Market Size by Country
6.3.1 North America Infectious Vaccines Sales by Country (2017-2028)
6.3.2 North America Infectious Vaccines Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Infectious Vaccines Market Size by Type
7.1.1 Europe Infectious Vaccines Sales by Type (2017-2028)
7.1.2 Europe Infectious Vaccines Revenue by Type (2017-2028)
7.2 Europe Infectious Vaccines Market Size by Application
7.2.1 Europe Infectious Vaccines Sales by Application (2017-2028)
7.2.2 Europe Infectious Vaccines Revenue by Application (2017-2028)
7.3 Europe Infectious Vaccines Market Size by Country
7.3.1 Europe Infectious Vaccines Sales by Country (2017-2028)
7.3.2 Europe Infectious Vaccines Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Infectious Vaccines Market Size by Type
8.1.1 Asia Pacific Infectious Vaccines Sales by Type (2017-2028)
8.1.2 Asia Pacific Infectious Vaccines Revenue by Type (2017-2028)
8.2 Asia Pacific Infectious Vaccines Market Size by Application
8.2.1 Asia Pacific Infectious Vaccines Sales by Application (2017-2028)
8.2.2 Asia Pacific Infectious Vaccines Revenue by Application (2017-2028)
8.3 Asia Pacific Infectious Vaccines Market Size by Region
8.3.1 Asia Pacific Infectious Vaccines Sales by Region (2017-2028)
8.3.2 Asia Pacific Infectious Vaccines Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Infectious Vaccines Market Size by Type
9.1.1 Latin America Infectious Vaccines Sales by Type (2017-2028)
9.1.2 Latin America Infectious Vaccines Revenue by Type (2017-2028)
9.2 Latin America Infectious Vaccines Market Size by Application
9.2.1 Latin America Infectious Vaccines Sales by Application (2017-2028)
9.2.2 Latin America Infectious Vaccines Revenue by Application (2017-2028)
9.3 Latin America Infectious Vaccines Market Size by Country
9.3.1 Latin America Infectious Vaccines Sales by Country (2017-2028)
9.3.2 Latin America Infectious Vaccines Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Infectious Vaccines Market Size by Type
10.1.1 Middle East and Africa Infectious Vaccines Sales by Type (2017-2028)
10.1.2 Middle East and Africa Infectious Vaccines Revenue by Type (2017-2028)
10.2 Middle East and Africa Infectious Vaccines Market Size by Application
10.2.1 Middle East and Africa Infectious Vaccines Sales by Application (2017-2028)
10.2.2 Middle East and Africa Infectious Vaccines Revenue by Application (2017-2028)
10.3 Middle East and Africa Infectious Vaccines Market Size by Country
10.3.1 Middle East and Africa Infectious Vaccines Sales by Country (2017-2028)
10.3.2 Middle East and Africa Infectious Vaccines Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 CSL Limited (Australia)
11.1.1 CSL Limited (Australia) Corporation Information
11.1.2 CSL Limited (Australia) Overview
11.1.3 CSL Limited (Australia) Infectious Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 CSL Limited (Australia) Infectious Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 CSL Limited (Australia) Recent Developments
11.2 Bavarian Nordic (Denmark)
11.2.1 Bavarian Nordic (Denmark) Corporation Information
11.2.2 Bavarian Nordic (Denmark) Overview
11.2.3 Bavarian Nordic (Denmark) Infectious Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Bavarian Nordic (Denmark) Infectious Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Bavarian Nordic (Denmark) Recent Developments
11.3 GlaxoSmithKline plc. (U.K.)
11.3.1 GlaxoSmithKline plc. (U.K.) Corporation Information
11.3.2 GlaxoSmithKline plc. (U.K.) Overview
11.3.3 GlaxoSmithKline plc. (U.K.) Infectious Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 GlaxoSmithKline plc. (U.K.) Infectious Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 GlaxoSmithKline plc. (U.K.) Recent Developments
11.4 Emergent Bio Solutions Inc. (U.S.)
11.4.1 Emergent Bio Solutions Inc. (U.S.) Corporation Information
11.4.2 Emergent Bio Solutions Inc. (U.S.) Overview
11.4.3 Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Emergent Bio Solutions Inc. (U.S.) Recent Developments
11.5 MedImmune LLC (U.S.)
11.5.1 MedImmune LLC (U.S.) Corporation Information
11.5.2 MedImmune LLC (U.S.) Overview
11.5.3 MedImmune LLC (U.S.) Infectious Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 MedImmune LLC (U.S.) Infectious Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 MedImmune LLC (U.S.) Recent Developments
11.6 Johnson and Johnson (U.S.)
11.6.1 Johnson and Johnson (U.S.) Corporation Information
11.6.2 Johnson and Johnson (U.S.) Overview
11.6.3 Johnson and Johnson (U.S.) Infectious Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Johnson and Johnson (U.S.) Infectious Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Johnson and Johnson (U.S.) Recent Developments
11.7 Novartis AG (Switzerland)
11.7.1 Novartis AG (Switzerland) Corporation Information
11.7.2 Novartis AG (Switzerland) Overview
11.7.3 Novartis AG (Switzerland) Infectious Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Novartis AG (Switzerland) Infectious Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Novartis AG (Switzerland) Recent Developments
11.8 Merck and Company (U.S.)
11.8.1 Merck and Company (U.S.) Corporation Information
11.8.2 Merck and Company (U.S.) Overview
11.8.3 Merck and Company (U.S.) Infectious Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Merck and Company (U.S.) Infectious Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Merck and Company (U.S.) Recent Developments
11.9 Sanofi Pasteur (France)
11.9.1 Sanofi Pasteur (France) Corporation Information
11.9.2 Sanofi Pasteur (France) Overview
11.9.3 Sanofi Pasteur (France) Infectious Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Sanofi Pasteur (France) Infectious Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Sanofi Pasteur (France) Recent Developments
11.10 Pfizer Inc. (U.S.)
11.10.1 Pfizer Inc. (U.S.) Corporation Information
11.10.2 Pfizer Inc. (U.S.) Overview
11.10.3 Pfizer Inc. (U.S.) Infectious Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Pfizer Inc. (U.S.) Infectious Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Pfizer Inc. (U.S.) Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Infectious Vaccines Industry Chain Analysis
12.2 Infectious Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Infectious Vaccines Production Mode & Process
12.4 Infectious Vaccines Sales and Marketing
12.4.1 Infectious Vaccines Sales Channels
12.4.2 Infectious Vaccines Distributors
12.5 Infectious Vaccines Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Infectious Vaccines Industry Trends
13.2 Infectious Vaccines Market Drivers
13.3 Infectious Vaccines Market Challenges
13.4 Infectious Vaccines Market Restraints
14 Key Findings in The Global Infectious Vaccines Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Infectious Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Preventive Vaccine
Table 3. Major Manufacturers of Therapeutic Vaccine
Table 4. Global Infectious Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Infectious Vaccines Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Infectious Vaccines Sales by Region (2017-2022) & (K Units)
Table 7. Global Infectious Vaccines Sales Market Share by Region (2017-2022)
Table 8. Global Infectious Vaccines Sales by Region (2023-2028) & (K Units)
Table 9. Global Infectious Vaccines Sales Market Share by Region (2023-2028)
Table 10. Global Infectious Vaccines Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Infectious Vaccines Revenue Market Share by Region (2017-2022)
Table 12. Global Infectious Vaccines Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Infectious Vaccines Revenue Market Share by Region (2023-2028)
Table 14. Global Infectious Vaccines Sales by Manufacturers (2017-2022) & (K Units)
Table 15. Global Infectious Vaccines Sales Share by Manufacturers (2017-2022)
Table 16. Global Infectious Vaccines Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Infectious Vaccines Revenue Share by Manufacturers (2017-2022)
Table 18. Infectious Vaccines Price by Manufacturers (2017-2022) &(USD/Unit)
Table 19. Global Infectious Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Infectious Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Vaccines as of 2021)
Table 21. Infectious Vaccines Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Infectious Vaccines Product Offered
Table 23. Date of Manufacturers Enter into Infectious Vaccines Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Infectious Vaccines Sales by Type (2017-2022) & (K Units)
Table 26. Global Infectious Vaccines Sales by Type (2023-2028) & (K Units)
Table 27. Global Infectious Vaccines Sales Share by Type (2017-2022)
Table 28. Global Infectious Vaccines Sales Share by Type (2023-2028)
Table 29. Global Infectious Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Infectious Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Infectious Vaccines Revenue Share by Type (2017-2022)
Table 32. Global Infectious Vaccines Revenue Share by Type (2023-2028)
Table 33. Infectious Vaccines Price by Type (2017-2022) & (USD/Unit)
Table 34. Global Infectious Vaccines Price Forecast by Type (2023-2028) & (USD/Unit)
Table 35. Global Infectious Vaccines Sales by Application (2017-2022) & (K Units)
Table 36. Global Infectious Vaccines Sales by Application (2023-2028) & (K Units)
Table 37. Global Infectious Vaccines Sales Share by Application (2017-2022)
Table 38. Global Infectious Vaccines Sales Share by Application (2023-2028)
Table 39. Global Infectious Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Infectious Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Infectious Vaccines Revenue Share by Application (2017-2022)
Table 42. Global Infectious Vaccines Revenue Share by Application (2023-2028)
Table 43. Infectious Vaccines Price by Application (2017-2022) & (USD/Unit)
Table 44. Global Infectious Vaccines Price Forecast by Application (2023-2028) & (USD/Unit)
Table 45. North America Infectious Vaccines Sales by Type (2017-2022) & (K Units)
Table 46. North America Infectious Vaccines Sales by Type (2023-2028) & (K Units)
Table 47. North America Infectious Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Infectious Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Infectious Vaccines Sales by Application (2017-2022) & (K Units)
Table 50. North America Infectious Vaccines Sales by Application (2023-2028) & (K Units)
Table 51. North America Infectious Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Infectious Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Infectious Vaccines Sales by Country (2017-2022) & (K Units)
Table 54. North America Infectious Vaccines Sales by Country (2023-2028) & (K Units)
Table 55. North America Infectious Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Infectious Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Infectious Vaccines Sales by Type (2017-2022) & (K Units)
Table 58. Europe Infectious Vaccines Sales by Type (2023-2028) & (K Units)
Table 59. Europe Infectious Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Infectious Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Infectious Vaccines Sales by Application (2017-2022) & (K Units)
Table 62. Europe Infectious Vaccines Sales by Application (2023-2028) & (K Units)
Table 63. Europe Infectious Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Infectious Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Infectious Vaccines Sales by Country (2017-2022) & (K Units)
Table 66. Europe Infectious Vaccines Sales by Country (2023-2028) & (K Units)
Table 67. Europe Infectious Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Infectious Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Infectious Vaccines Sales by Type (2017-2022) & (K Units)
Table 70. Asia Pacific Infectious Vaccines Sales by Type (2023-2028) & (K Units)
Table 71. Asia Pacific Infectious Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Infectious Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Infectious Vaccines Sales by Application (2017-2022) & (K Units)
Table 74. Asia Pacific Infectious Vaccines Sales by Application (2023-2028) & (K Units)
Table 75. Asia Pacific Infectious Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Infectious Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Infectious Vaccines Sales by Region (2017-2022) & (K Units)
Table 78. Asia Pacific Infectious Vaccines Sales by Region (2023-2028) & (K Units)
Table 79. Asia Pacific Infectious Vaccines Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Infectious Vaccines Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Infectious Vaccines Sales by Type (2017-2022) & (K Units)
Table 82. Latin America Infectious Vaccines Sales by Type (2023-2028) & (K Units)
Table 83. Latin America Infectious Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Infectious Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Infectious Vaccines Sales by Application (2017-2022) & (K Units)
Table 86. Latin America Infectious Vaccines Sales by Application (2023-2028) & (K Units)
Table 87. Latin America Infectious Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Infectious Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Infectious Vaccines Sales by Country (2017-2022) & (K Units)
Table 90. Latin America Infectious Vaccines Sales by Country (2023-2028) & (K Units)
Table 91. Latin America Infectious Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Infectious Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Infectious Vaccines Sales by Type (2017-2022) & (K Units)
Table 94. Middle East and Africa Infectious Vaccines Sales by Type (2023-2028) & (K Units)
Table 95. Middle East and Africa Infectious Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Infectious Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Infectious Vaccines Sales by Application (2017-2022) & (K Units)
Table 98. Middle East and Africa Infectious Vaccines Sales by Application (2023-2028) & (K Units)
Table 99. Middle East and Africa Infectious Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Infectious Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Infectious Vaccines Sales by Country (2017-2022) & (K Units)
Table 102. Middle East and Africa Infectious Vaccines Sales by Country (2023-2028) & (K Units)
Table 103. Middle East and Africa Infectious Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Infectious Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 105. CSL Limited (Australia) Corporation Information
Table 106. CSL Limited (Australia) Description and Major Businesses
Table 107. CSL Limited (Australia) Infectious Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 108. CSL Limited (Australia) Infectious Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. CSL Limited (Australia) Recent Developments
Table 110. Bavarian Nordic (Denmark) Corporation Information
Table 111. Bavarian Nordic (Denmark) Description and Major Businesses
Table 112. Bavarian Nordic (Denmark) Infectious Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 113. Bavarian Nordic (Denmark) Infectious Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Bavarian Nordic (Denmark) Recent Developments
Table 115. GlaxoSmithKline plc. (U.K.) Corporation Information
Table 116. GlaxoSmithKline plc. (U.K.) Description and Major Businesses
Table 117. GlaxoSmithKline plc. (U.K.) Infectious Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 118. GlaxoSmithKline plc. (U.K.) Infectious Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. GlaxoSmithKline plc. (U.K.) Recent Developments
Table 120. Emergent Bio Solutions Inc. (U.S.) Corporation Information
Table 121. Emergent Bio Solutions Inc. (U.S.) Description and Major Businesses
Table 122. Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 123. Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Emergent Bio Solutions Inc. (U.S.) Recent Developments
Table 125. MedImmune LLC (U.S.) Corporation Information
Table 126. MedImmune LLC (U.S.) Description and Major Businesses
Table 127. MedImmune LLC (U.S.) Infectious Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 128. MedImmune LLC (U.S.) Infectious Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. MedImmune LLC (U.S.) Recent Developments
Table 130. Johnson and Johnson (U.S.) Corporation Information
Table 131. Johnson and Johnson (U.S.) Description and Major Businesses
Table 132. Johnson and Johnson (U.S.) Infectious Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 133. Johnson and Johnson (U.S.) Infectious Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Johnson and Johnson (U.S.) Recent Developments
Table 135. Novartis AG (Switzerland) Corporation Information
Table 136. Novartis AG (Switzerland) Description and Major Businesses
Table 137. Novartis AG (Switzerland) Infectious Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 138. Novartis AG (Switzerland) Infectious Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Novartis AG (Switzerland) Recent Developments
Table 140. Merck and Company (U.S.) Corporation Information
Table 141. Merck and Company (U.S.) Description and Major Businesses
Table 142. Merck and Company (U.S.) Infectious Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 143. Merck and Company (U.S.) Infectious Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Merck and Company (U.S.) Recent Developments
Table 145. Sanofi Pasteur (France) Corporation Information
Table 146. Sanofi Pasteur (France) Description and Major Businesses
Table 147. Sanofi Pasteur (France) Infectious Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 148. Sanofi Pasteur (France) Infectious Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Sanofi Pasteur (France) Recent Developments
Table 150. Pfizer Inc. (U.S.) Corporation Information
Table 151. Pfizer Inc. (U.S.) Description and Major Businesses
Table 152. Pfizer Inc. (U.S.) Infectious Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 153. Pfizer Inc. (U.S.) Infectious Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Pfizer Inc. (U.S.) Recent Developments
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Infectious Vaccines Distributors List
Table 158. Infectious Vaccines Customers List
Table 159. Infectious Vaccines Market Trends
Table 160. Infectious Vaccines Market Drivers
Table 161. Infectious Vaccines Market Challenges
Table 162. Infectious Vaccines Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Infectious Vaccines Product Picture
Figure 3. Global Infectious Vaccines Market Share by Type in 2021 & 2028
Figure 3. Preventive Vaccine Product Picture
Figure 4. Therapeutic Vaccine Product Picture
Figure 5. Global Infectious Vaccines Market Share by Application in 2021 & 2028
Figure 6. Adults
Figure 7. Pediatrics
Figure 8. Infectious Vaccines Report Years Considered
Figure 9. Global Infectious Vaccines Sales 2017-2028 (K Units)
Figure 10. Global Infectious Vaccines Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Infectious Vaccines Revenue 2017-2028 (US$ Million)
Figure 12. Global Infectious Vaccines Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 13. Global Infectious Vaccines Sales Market Share by Region (2017-2022)
Figure 14. Global Infectious Vaccines Sales Market Share by Region (2023-2028)
Figure 15. North America Infectious Vaccines Sales YoY (2017-2028) & (K Units)
Figure 16. North America Infectious Vaccines Revenue YoY (2017-2028) & (US$ Million)
Figure 17. Europe Infectious Vaccines Sales YoY (2017-2028) & (K Units)
Figure 18. Europe Infectious Vaccines Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Asia-Pacific Infectious Vaccines Sales YoY (2017-2028) & (K Units)
Figure 20. Asia-Pacific Infectious Vaccines Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Latin America Infectious Vaccines Sales YoY (2017-2028) & (K Units)
Figure 22. Latin America Infectious Vaccines Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Middle East & Africa Infectious Vaccines Sales YoY (2017-2028) & (K Units)
Figure 24. Middle East & Africa Infectious Vaccines Revenue YoY (2017-2028) & (US$ Million)
Figure 25. The Infectious Vaccines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 26. The Top 5 and 10 Largest Manufacturers of Infectious Vaccines in the World: Market Share by Infectious Vaccines Revenue in 2021
Figure 27. Global Infectious Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 28. Global Infectious Vaccines Sales Market Share by Type (2017-2028)
Figure 29. Global Infectious Vaccines Revenue Market Share by Type (2017-2028)
Figure 30. Global Infectious Vaccines Sales Market Share by Application (2017-2028)
Figure 31. Global Infectious Vaccines Revenue Market Share by Application (2017-2028)
Figure 32. North America Infectious Vaccines Sales Market Share by Type (2017-2028)
Figure 33. North America Infectious Vaccines Revenue Market Share by Type (2017-2028)
Figure 34. North America Infectious Vaccines Sales Market Share by Application (2017-2028)
Figure 35. North America Infectious Vaccines Revenue Market Share by Application (2017-2028)
Figure 36. North America Infectious Vaccines Sales Share by Country (2017-2028)
Figure 37. North America Infectious Vaccines Revenue Share by Country (2017-2028)
Figure 38. U.S. Infectious Vaccines Revenue (2017-2028) & (US$ Million)
Figure 39. Canada Infectious Vaccines Revenue (2017-2028) & (US$ Million)
Figure 40. Europe Infectious Vaccines Sales Market Share by Type (2017-2028)
Figure 41. Europe Infectious Vaccines Revenue Market Share by Type (2017-2028)
Figure 42. Europe Infectious Vaccines Sales Market Share by Application (2017-2028)
Figure 43. Europe Infectious Vaccines Revenue Market Share by Application (2017-2028)
Figure 44. Europe Infectious Vaccines Sales Share by Country (2017-2028)
Figure 45. Europe Infectious Vaccines Revenue Share by Country (2017-2028)
Figure 46. Germany Infectious Vaccines Revenue (2017-2028) & (US$ Million)
Figure 47. France Infectious Vaccines Revenue (2017-2028) & (US$ Million)
Figure 48. U.K. Infectious Vaccines Revenue (2017-2028) & (US$ Million)
Figure 49. Italy Infectious Vaccines Revenue (2017-2028) & (US$ Million)
Figure 50. Russia Infectious Vaccines Revenue (2017-2028) & (US$ Million)
Figure 51. Asia Pacific Infectious Vaccines Sales Market Share by Type (2017-2028)
Figure 52. Asia Pacific Infectious Vaccines Revenue Market Share by Type (2017-2028)
Figure 53. Asia Pacific Infectious Vaccines Sales Market Share by Application (2017-2028)
Figure 54. Asia Pacific Infectious Vaccines Revenue Market Share by Application (2017-2028)
Figure 55. Asia Pacific Infectious Vaccines Sales Share by Region (2017-2028)
Figure 56. Asia Pacific Infectious Vaccines Revenue Share by Region (2017-2028)
Figure 57. China Infectious Vaccines Revenue (2017-2028) & (US$ Million)
Figure 58. Japan Infectious Vaccines Revenue (2017-2028) & (US$ Million)
Figure 59. South Korea Infectious Vaccines Revenue (2017-2028) & (US$ Million)
Figure 60. India Infectious Vaccines Revenue (2017-2028) & (US$ Million)
Figure 61. Australia Infectious Vaccines Revenue (2017-2028) & (US$ Million)
Figure 62. Taiwan Infectious Vaccines Revenue (2017-2028) & (US$ Million)
Figure 63. Indonesia Infectious Vaccines Revenue (2017-2028) & (US$ Million)
Figure 64. Thailand Infectious Vaccines Revenue (2017-2028) & (US$ Million)
Figure 65. Malaysia Infectious Vaccines Revenue (2017-2028) & (US$ Million)
Figure 66. Philippines Infectious Vaccines Revenue (2017-2028) & (US$ Million)
Figure 67. Latin America Infectious Vaccines Sales Market Share by Type (2017-2028)
Figure 68. Latin America Infectious Vaccines Revenue Market Share by Type (2017-2028)
Figure 69. Latin America Infectious Vaccines Sales Market Share by Application (2017-2028)
Figure 70. Latin America Infectious Vaccines Revenue Market Share by Application (2017-2028)
Figure 71. Latin America Infectious Vaccines Sales Share by Country (2017-2028)
Figure 72. Latin America Infectious Vaccines Revenue Share by Country (2017-2028)
Figure 73. Mexico Infectious Vaccines Revenue (2017-2028) & (US$ Million)
Figure 74. Brazil Infectious Vaccines Revenue (2017-2028) & (US$ Million)
Figure 75. Argentina Infectious Vaccines Revenue (2017-2028) & (US$ Million)
Figure 76. Middle East and Africa Infectious Vaccines Sales Market Share by Type (2017-2028)
Figure 77. Middle East and Africa Infectious Vaccines Revenue Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Infectious Vaccines Sales Market Share by Application (2017-2028)
Figure 79. Middle East and Africa Infectious Vaccines Revenue Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Infectious Vaccines Sales Share by Country (2017-2028)
Figure 81. Middle East and Africa Infectious Vaccines Revenue Share by Country (2017-2028)
Figure 82. Turkey Infectious Vaccines Revenue (2017-2028) & (US$ Million)
Figure 83. Saudi Arabia Infectious Vaccines Revenue (2017-2028) & (US$ Million)
Figure 84. U.A.E Infectious Vaccines Revenue (2017-2028) & (US$ Million)
Figure 85. Infectious Vaccines Value Chain
Figure 86. Infectious Vaccines Production Process
Figure 87. Channels of Distribution
Figure 88. Distributors Profiles
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed
Global Diffusion Bonded Manifo
Published Date: 2022-02-22 | Pages: 87 Pages | Tables: 739
USD 4,900 Single License USD 9,800 Enterprise License
Global Commercial Laundry Syst
Published Date: 2022-02-12 | Pages: 117 Pages | Tables: 935
USD 4,900 Single License USD 9,800 Enterprise License
Global and United States Autom
Published Date: 2022-02-21 | Pages: 102 Pages | Tables: 957
USD 4,350 Single License USD 8,700 Enterprise License
Global Red Chili Seeds Market
Published Date: 2022-02-17 | Pages: 112 Pages | Tables: 994
USD 4,900 Single License USD 9,800 Enterprise License
Global 2.4GHz Router Market In
Published Date: 2022-02-16 | Pages: 110 Pages | Tables: 819
USD 4,900 Single License USD 9,800 Enterprise License
